首页/数据集/Gastroenterologist-stated prescribing of biosimilars currently and expected in 12 months.

Gastroenterologist-stated prescribing of biosimilars currently and expected in 12 months.

NIAID Data Ecosystem2026-03-10 收录

数据链接：

https://figshare.com/articles/dataset/Gastroenterologist-stated_prescribing_of_biosimilars_currently_and_expected_in_12_months_/4879022 数据链接链接失效反馈

官方服务：

资源简介：

Gastroenterologist-stated prescribing of biosimilars currently and expected in 12 months.

应用场景：

创建时间：

2017-04-15

消化系统疾病临床实践

临床试验质量

Objectives: To evaluate the adequacy of reporting of protocols for randomised trials on diseases of the digestive system registered in ClinicalTrials.gov and the consistency between primary outcomes,

DataONE2011-09-30 更新40

Characteristics of randomised trials on diseases in the digestive system registered in ClinicalTrials.gov - a retrospective analysis

消化系统疾病临床实践

试验注册数据质量

Objectives: To evaluate the adequacy of reporting of protocols for randomised trials on diseases of the digestive system registered in ClinicalTrials.gov and the consistency between primary outcomes,

NIAID Data Ecosystem20

Prevalence of Helicobacter pylori eradication therapy.

幽门螺杆菌治疗

消化系统疾病临床实践

Prevalence of Helicobacter pylori eradication therapy.

NIAID Data Ecosystem20

Supplementary Material for: Management of Gastroesophageal Reflux Disease in Asian Countries: Results of a Questionnaire Survey

胃食管反流病管理

消化系统疾病临床实践

Introduction: The Asia-Pacific consensus on the management of gastroesophageal reflux disease (GERD) and the GERD treatment guidelines of 2015 drawn up by the Japanese Society of Gastroenterology were

Figshare2019-12-04 更新30

Supplementary Material for: Impact of the COVID-19 Pandemic on Gastroenterology Department Activity: The Gastroenterologist’s Perspective Nationwide and the Real Impact in a Portuguese Center

消化系统疾病临床实践

疫情医疗影响评估

Background: Several gastroenterology societies have created recommendations in order to reduce nonessential exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Our aim

Figshare2021-07-21 更新20

Gastroenterologist-stated prescribing of biosimilars currently and expected in 12 months.

资源简介：

相关数据集